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ABSTRACT
The scope and coverage of the Brazilian Immunization Program can be 
compared with those in developed countries because it provides a large 
number of vaccines and has a considerable coverage. The increasing 
complexity of the program brings challenges regarding its development, high 
coverage levels, access equality, and safety. The Immunization Information 
System, with nominal data, is an innovative tool that can more accurately 
monitor these indicators and allows the evaluation of the impact of new 
vaccination strategies. The main difficulties for such a system are in its 
implementation process, training of professionals, mastering its use, its 
constant maintenance needs and ensuring the information contained remain 
confidential. Therefore, encouraging the development of this tool should be 
part of public health policies and should also be involved in the three spheres 
of government as well as the public and private vaccination services. 
DESCRIPTORS: Immunization Programs. Electronic Health Records. 
Medical Records Systems, Computerized. Immunization Coverage. 
RESUMO
A abrangência e desempenho do Programa Nacional de Imunização no Brasil 
são comparáveis aos de países desenvolvidos, pois oferece número elevado 
de vacinas e cobertura considerável. A crescente complexidade do Programa 
acarreta desafios inerentes ao seu desenvolvimento, em relação à manutenção 
de coberturas vacinais elevadas, equidade de acesso e segurança. O sistema 
informatizado de imunização, com dados nominais, é um instrumento inovador 
para o monitoramento preciso desses indicadores e permite a avaliação de 
impacto das novas estratégias de vacinação. Suas principais dificuldades 
estão no processo de implantação, treinamento dos profissionais, domínio da 
tecnologia, e sua constante manutenção e garantia da confidencialidade das 
informações. O incentivo ao desenvolvimento dessa ferramenta deve fazer 
parte das políticas públicas em saúde e contar com o envolvimento das três 
esferas de governo e das redes de vacinação pública e privada. 
DESCRITORES: Programas de Imunização. Registros Eletrônicos 
de Saúde. Sistemas Computadorizados de Registros Médicos. 
Cobertura Vacinal.
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INTRODUCTION
The scope and performance of Brazil’s National 
Immunization Program (NIP) is comparable to those 
of developed countries.10 The program is growing in 
complexity both because a number of vaccines have 
already been made available in the routine schedule 
in a short period of time, and due to the inclusion of 
combined vaccines and the supply of already avail-
able vaccines to population groups who were not, until 
recently, covered by the program.6
This advance brings undoubted benefits, but it also 
highlights the challenges that are inherent for the devel-
opment and success of the NPI, such as: logistical issues 
(cold chain and production of immunobiologicals); 
maintaining a homogeneously high coverage for all 
vaccines; verifying and monitoring the perceived risk 
of the disease and of adverse events following vacci-
nation (AEFV); identifying factors that are associated 
with noncompliance; and preventing already controlled 
diseases from reemerging.6,13,23
Incorporating new technologies, such as computer-
ized systems for recording vaccination with nominal 
data, is critical to maintain the good quality of this 
program.3,12,13,16,23 These systems are useful tools for 
scheduling vaccinations, identifying and searching for 
missing patients and monitoring vaccination coverage 
and AEFV.12 In addition, together with other informa-
tion systems in health and the sociodemographic, it 
shows itself to be an important tool for planning and 
evaluating public health activities.12
The NPI Information System (NPI-IS), which stores 
nominal data, is in the process of being implemented 
and can be seen as a tool to address the aforemen-
tioned challenges.
The aim of this article is to discuss the computerized 
system’s potential regarding vaccination and important 
aspects such as vaccine coverage evaluation, adverse 
events monitoring and academic research, as well as 
its challenges and limitations.
IMMUNIZATION INFORMATION SYSTEM
Since the 1970s, some countries such as Great Britain, 
the United States (USA) and Canada began using 
Immunization Information Systems (IIS) to make the 
vaccination programs more integrated.12
The IIS is an electronic, confidential and population-
based database designed to collect and consolidate 
vaccination data to be used for conceiving and main-
taining effective immunization strategies.3
In operational terms, the IIS can provide consis-
tent information regarding vaccination history of 
individuals throughout their life. The system auto-
matically gives notification when a vaccination is due 
and when it is late. It also provides active AEFI moni-
toring and helps giving indications and contraindica-
tions as well as information about a vaccine’s shelf life 
and availability.
At the populational level, an IIS is important to 
provide monitoring, evaluate responses to outbreaks, 
verify disparities in immunization coverage and offer 
decision-making support. With a better coverage, the 
rates of immunopreventable diseases are reduced, which 
makes the IIS an important tool for planning health 
services and evaluating the care that is provided.3,12
IIS in Brazil
In Brazil, municipal and national initiatives that focus 
on developing information systems in health show 
a tendency to incorporate these instruments in their 
services and management. The Cartão Nacional de 
Saúde (National Health Card) was an important step as 
it integrates different sources of electronic information 
from patients/users and builds a health database using 
the citizen’s identification number.4 This is in alignment 
with the Mais Saúde (More Health) strategic plan, in 
the Management Training plan, and aims to promote 
access to health services that is equal for all.
Specifically in the area of immunization, Brazil has 
relied on important instruments since the 1990s. The 
oldest IIS is in Serviço Especial de Saúde de Araraquara 
da Faculdade de Saúde Pública da Universidade de 
São Paulo (USP), which was developed by the Centro 
de Tecnologia da Informação de São Carlos (USP). In 
2009, a survey was published and included informa-
tion stating that IIS existed in 62 Brazilian cities.12 It 
is believe that this number is currently higher, as the 
NPI-IS, in the process of being implemented, has been 
functional in some cities since 2010.6
Currently, the flow of information from the NPI makes 
it possible to perform monthly follow-ups of vaccina-
tion activities regarding the quantity of distributed and 
applied doses, coverage and AEFI.6 This system has 
limitations that arise from calculating immunization 
coverage, which makes use of population estimates 
in the denominator and records applied doses in the 
numerator. Results are influenced by incorrect data 
caused by migration, populational mobility and errors 
in the estimation of the population and applied doses.
During the quest to improve the quality of information, 
the NPI-IS was developed and is the process of being 
implemented that will make it possible to evaluate 
coverage more accurately and identify vaccinated indi-
viduals. The NPI-IS will gather together, in a single data-
base, subsystems that will provide data regarding vacci-
nation coverage and dropout rate, in addition to AEFI 
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and immunobiological calculations used in the network 
and at Reference Centers for Special Immunobiologicals.
Among the data in the system, it is possible to identify 
the vaccinated and their origins, allowing the unvac-
cinated to be found and given a dose. The single iden-
tifying number used in the NPI-IS will be the one 
shown on the “National Health Card”, which will 
subsequently allow different national databases to be 
related together.6
IIS POTENTIAL
Vaccine coverage evaluation
Brazil has a good level of vaccinal coverage, however this 
is not uniform.6 Surveys indicate an inequality in vaccinal 
coverage in Brazilian cities and areas of low intramunic-
ipal coverage.1,23 Generally speaking, studies show that 
areas with the greatest coverage are those with the worst 
socioeconomic indicators, which suggest equal access to 
vaccine.1,13 However, more investigation is necessary to 
discover if this situation happens in different contexts, 
namely in the Brazilian reality. In addition, it is also impor-
tant to consider private medical care in the population’s 
vaccination, as this group has a strong participation in such.
The IIS will improve this evaluation because it makes 
it possible to evaluate complete immunization sched-
ules, validity of applied doses (minimum time gap 
between doses) and timely or late vaccine administra-
tion. However, it is worth highlighting the importance 
of monitoring vaccinal coverage, while considering 
different aspects and allowing micro-areas with lesser 
coverage to be identified.
Moreover, the IIS increase vaccinal coverage by 
scheduling vaccination (remind) and identifying and 
searching for missing patients (recall).12 Studies indi-
cate that these reminding systems improve coverage in 
children and adults for all vaccines. Reminding strate-
gies range from phone calls, which are the most effec-
tive, to letters and home visits.11
Studies have also evaluated automatic text messages 
to individuals reminding them about their vaccination. 
During a randomized and controlled trial, performed in 
the USA and aimed at children and adolescents to have 
a vaccination against influenza, an increase in vaccinal 
coverage was observed, despite still remaining low.21 
Another evaluation of this strategy’s effectiveness, 
which was performed in Great Britain, exemplifies the 
importance of this instrument.9
Monitoring adverse events
As vaccination programs achieve their objective of 
controlling diseases, vaccine safety becomes a more 
obvious question due to the decrease in risk percep-
tion surrounding immunopreventable diseases and the 
increase in AEFI awareness.24 Additionally, the increased 
frequency of combined vaccines being introduced has 
made evaluating these events even more complex.
IIS make it possible to create an active AEFI monitoring 
system and can assist in vaccine pharmacovigilance. 
Results from a study that investigated the viability of 
this strategy were positive and promising, especially for 
detecting predefined signs of these events. One major 
challenge is defining which AEFI should be monitored 
and what magnitude of change, in its frequency, should 
be a trigger for alert.5 Another example was the active 
AEFI monitoring with the Vaccine Safety Datalink in 
the USA.25 This compared the observed number of 
AEFI with the expected number, with the base being 
the known rate from previous periods. Whenever the 
observed number was larger than what was expected, 
the manager was sent an alert. Only ten alerts were sent 
over a three-year period, one of these being genuine; 
however, it was this that was responsible for the change 
in immunization policy in the USA.25
The introduction of combined vaccines enabled this 
Program’s operationalization (immunogens being 
applied for various diseases in a single injection); 
however, AEFI evaluation was made difficult as was 
immunobiological safety as a result.7
Therefore, IIS instruments have potential for the evalu-
ation of AEFI because they improve data quality, better 
define the outcomes and make comparisons between 
groups more effective.24
Research opportunities
IIS can reduce fragmentation in vaccination records and 
improve service provision. This resource also makes 
it possible for the data to be used in vaccine efficiency 
studies, with methodological advantages over tradi-
tional observational ones.
The availability of individualized information means 
that cohort studies can be performed. These kind of 
studies can be conducted even in conditions where 
a disease has a low frequency of incidence, which 
is due to the vast quantity of data that is available. 
The comprehensive and accurate nature of informa-
tion regarding the state of individual vaccination 
definition avoids differential bias between cases and 
controls. However, the IIS demands a clearly defined 
population-base and accuracy in recording vaccination 
for studies to achieve validity.8,14 A paired case-control 
study,20 based on the UK General Practice Research 
Database, exemplifies the use of IIS in research. This 
research showed that the vaccination against measles, 
mumps and rubella was not associated with an increased 
risk of autism or specific developmental disorders.20
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IIS are useful tools as they assess the impact of immuni-
zation programs by evaluating vaccines’ effectiveness on 
different populations, contexts and diseases. However, 
information quality and IIS representativeness must be 
carefully monitored (vaccination data), as well as data 
regarding the incidence of the disease in question.
Various vaccines have been introduced in the NPI 
during the last decade. However evaluations must be 
performed regarding their effectiveness, while consid-
ering the different contexts, given the continental 
dimensions of Brazil and the large regional disparities.
IIS CHALLENGES AND LIMITATIONS
In spite of the advantages of having electronic health 
records, studies have highlighted the gap between the 
expectations and the improvements taking place in the 
service.2,15 A lack of integration within health care and 
quality heterogeneity in the comprehensiveness and 
accuracy of data stand out among the principle prob-
lems.15 Implementing the instrument demands, in addi-
tion to acquiring and maintaining the technology, an 
organizational change, financial incentive, certification 
criteria, interoperability standards and participation in 
the national health policy agenda.19
IIS also face challenges concerning its operationalization, 
integrality and data quality (duplicity and under-recording), 
as well as in its technology implementation process in 
Brazil and ability to guarantee information confidentiality.12
The NPI-IS, developed by the Brazilian Unified Health 
System (SUS), is already being used in some cities of our 
Country. In addition, some sites have their own systems 
that have the ability to export archives to the NPI-IS. In 
2012, by way of Decree 2,336/2012, the Brazilian Health 
Ministry built 34,000 vaccination rooms, for the public 
network, that were equipped with computer systems.
Training for the professionals of the services and moni-
toring in heath also requires effort from the municipal, 
state and national health bodies. Moreover, the private 
health sector must be involved in this process.
The NPI has already performed various training 
schemes with view to implement the NPI-IS in a 
timely manner. The team that is responsible for the tool 
has also made video-lessons and has been constantly 
updating an instructive manual that contains information 
regarding the system’s resources, and how to use them. 
Furthermore, some states, such as Sao Paulo, have been 
using the Internet to update themes related to vaccination.
The initial NPI-IS system is a desktop version and can 
only be used offline, with the local health departments 
being responsible for sending data directly to the NPI, 
doing so by sending encrypted file on the website. The 
online system is currently in development. Therefore, 
other challenges inherent to NPI-IS system implemen-
tation are: having a good quality internet connection; a 
suitable and timely vaccination record when the system 
is offline; duplicate records, because vaccines rooms 
in the same municipality are not able to communicate 
with each or constantly update data, so that an indi-
vidual registered in one health care facility is likely to 
be re-registered in another unit in the same city.
Studies have shown that IIS have good cost effective-
ness attributes, with better performance in areas that 
have low vaccinal coverage and a larger scale opera-
tion. Costs can grow when new functions are added to 
the system, such as vaccine management, alerting for 
adverse events and connecting with other databases. 
However, the benefits certainly outweigh the costs, 
given that individual information makes it possible to 
better assess vaccination activities.12 In addition, due 
to the fact that the vaccination schedule is complex in 
regarding the recommended age for each vaccine, inter-
vals between doses and the high number of immuno-
biologicals, IIS may assist to operationalize vaccina-
tion activities, as they can define when the next vaccine 
dose will be for every child.
About the research incentive, developing innovative 
instruments has been among the themes of the Brazilian 
National Agenda for Research Priorities in Health, which 
was created in 2003.18 These incentives in innovation and 
technological development, whether in vaccine produc-
tion, in the cold chain or in the information system, have 
reflected favorably on the development of the NIP.
FINAL CONSIDERATIONS
IIS provide more consistent data than estimates that are 
based on applied doses for evaluating vaccinal coverage 
and AEFI, which makes the tool important for plan-
ning and evaluating activities with a view to increase 
the number of vaccines applied.
Using this system means that areas with low coverage 
can be identified, thereby improving social equality 
for the access to immunobiologicals and health care in 
general. It also made active AEFI monitoring possible, 
which must be a priority with combined vaccine being 
introduced. IIS that are related to other nominal data-
bases are useful sources of information for studies that 
evaluate the impact of vaccines.
The NPI-IS can be considered as a strategy to integrate 
nominal data from Brazilian individuals, which began 
from a pivotal public policy. Therefore, the system’s 
implementation and evaluation should have a place on the 
national political agenda and involve both the government, 
as well as the population and public and private services. 
These conditions can make it possible to create a compre-
hensive computerized system and integrated health care to 
meet the demands of a complex immunization program.
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